Clinical trial
Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as…
NCT00016458 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00016458 |
|---|---|
| Title | Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Systemic Sclerosis |
| Intervention type | Drug |
| Interventions | anti-thymocyte globulin, cyclophosphamide |
| Enrollment | 20 |
| Start date | Jun 1, 2000 |
| First posted | May 7, 2001 |
| Last update posted | Sep 3, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: